News
2d
Pharmaceutical Technology on MSNFDA free to pursue semaglutide compounders after latest court rulingDespite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final ...
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...
New Delhi: Torrent Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...
16h
inews.co.uk on MSNThe unexpected benefits of weight loss jabs – and the downsidesDoctors are learning more about the wider effects of the injections, from lowering blood pressure to helping people quit ...
Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...
Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...
5dOpinion
Montreal Gazette on MSNChristopher Labos: Ozempic’s oral counterpart hasn’t caught on yetThe prospect of a pill rather than an injection is obviously appealing to some people, but will fear of needles be enough to ...
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
Conduct CT in India: CDSCO Panel tells Novo Nordisk India For new formulation of Semaglutide tablets
The committee noted that semaglutide tablets 3 mg, 7 mg, and 14 mg are approved for marketing in India. The firm has claimed ...
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results